Author Archives: Guest Blogger

Five Ways Advanced Social Intelligence Guides Pharma Strategy

By Guest Blogger | Published: June 4, 2013
by Mark Langsfeld Within the billions of daily comments from individuals across open social sources lies deep intelligence into markets, brands, patients, caregivers, healthcare providers and competitors. Several leading pharmaceutical companies are already using big data solutions to extract insights from the social realm. Applying these insights across a number of business functions empowers their decision-making [...]
Posted in Patient Communication | Tagged , , | 1 Comment

Drug Patents Under Fire in Brazil

By Guest Blogger | Published: June 4, 2013
by Ryan O’Quinn & Sanya Sukduang One of the most promising pharmaceutical markets of the future is Brazil, a nation of nearly 200 million people with a universal healthcare system.  Brazil’s infamously overloaded patent system has undergone a series of recent reforms.  One such “reform,” however, greatly complicates biopharmaceutical patent practice: any Brazilian patent application for [...]
Posted in Regulatory | Tagged , , , , , , | Leave a comment

European Clinical Trials Policy Gets Caught Up in Politics

By Guest Blogger | Published: June 3, 2013
The latest stage of Europe’s attempt to update its clinical trials rules offered a mildly distressing spectacle of the intrusion of politics into policy, writes Peter O’ Donnell. It is inevitable, of course, that legislation should be colored by politics in any democracy, since legislators, being elected, are by nature political animals. But in an area [...]
Posted in Guest Blog | Tagged , , , | 1 Comment

Should Pharma Do Tumblr?

By Guest Blogger | Published: May 22, 2013
Could acquisition by Yahoo make Tumblr more interesting to Pharma? I’m sure you’ve heard already – Internet geriatric Yahoo just bought six-year old Tumblr for $1.1 billion. The deal, likely to complete in the second half of this year, is almost all cash – reportedly almost all the cash Yahoo had in hand at the close [...]
Posted in Guest Blog, Op-Ed, Technology, social media | Tagged , , , | 3 Comments

Your 2014 Medicaid Sales & Marketing Plans

By Guest Blogger | Published: May 21, 2013
by Tom Norton If you are an Rx regional sales director or a product marketing manager, I have a somewhat provocative question for you:  How exactly are you planning your 2014 Medicaid strategy?
Posted in Advertising, Guest Blog, Legal, Market Access, Marketing, Regulatory, Sales, Strategy, healthcare, pricing | Tagged , , , , , , , , , , | Leave a comment